Tiskové zprávy

The Mercator Medical Group recorded significant increases in sales revenues and EBITDA.

The Krakow-based manufacturer of medical gloves started 2016 very well. The consolidated report for Q1 2016 published o…

The Krakow-based manufacturer of medical gloves started 2016 very well. The consolidated report for Q1 2016 published on 16 May 2016 confirms the previously visible positive dynamics of results of the Mercator Medical S.A. Group.

In Q1 2016, the Mercator Medical Capital Group reported an increase in sales revenues of more than 24% YOY. Revenues from sales of goods purchased from external suppliers increased, as well as revenues from the sales of gloves produced at the company’s own manufacturing plant in Thailand.

The sales dynamics of goods amounted to +22%, and in the most important segment of examination gloves, volume sales increased by almost 20%. Thanks to the completed extension of the medical gloves factory in Thailand, revenues from sales of products from the company’s own factory increased by over 28% YOY.

EBITDA reached the value of PLN 6 million and increased by PLN 0.9 million YOY (i.e. by 17.9%). EBITDA profitability as a % of sales was 10.1%.

Significant increases in sales were observed mainly in Poland, Russia, the United States
and South Africa. In the United States, bulk container deliveries of products originating from the Thailand factory are mainly carried out. In 2016, we also reached new markets, i.e. Kazakhstan and Sweden. We are convinced that we will reach other new places with our products”, says Leszek Michnowski, Vice President of the Management Board.

At the turn of 2015/2016, the Group’s composition was expanded to include a Czech subsidiary, Mercator Medical s.r.o based in Brno, which started operating activities in Q1 of the current year – to date sales in the Czech and Slovak regions were conducted from Poland. The Mercator Medical Capital Group has been consistently developing the distribution network, building customer relationships and increasing stock availability, which allows to reinforce its position on the Polish market and in other countries of Central and Eastern Europe.

We have been working to reach new customers and expand our collaboration with existing customers. The effects are positive, as demonstrated by the presented sales figures. Our successes would not be possible without the persistent, long-standing, consistent efforts to build trust in Mercator Medical among our customers and to build a competitive advantage on the market”, adds Leszek Michnowski. The Group is planning to further expand the factory in Thailand by the addition of 8 new lines for the manufacture of gloves with a total capacity of around 150 million items per month. The estimated cost of the investment is expected to be approximately PLN 107 million. The subsidiary in Thailand concluded loan agreements in March 2016 in order to finance this investment.

The new project will ensure an increased capacity of plants owned by Medical Thailand Ltd. from 100 to 250 million gloves per month and will increase employment to over 800 people. The Mercator Medical Group will reinforce its position as a global glove manufacturer”,
says Leszek Michnowski.

We encourage you to read the entire Q1 2016 report.

To jest wyrób medyczny. Używaj go zgodnie z instrukcją używania lub etykietą.